SIAP
CVS icon

Sterling Investment Advisors (Pennsylvania)’s CVS Health CVS Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-39,052
Closed -$2.7M – 138
2023
Q2 		$2.7M Sell
39,052
-5,105
-12% -$363K 0.89% 34
2023
Q1 		$3.28M Buy
44,157
+2,747
+7% +$230K 1.11% 27
2022
Q4 		$3.86M Buy
41,410
+339
+0.8% +$32.7K 1.38% 20
2022
Q3 		$3.92M Buy
41,071
+81
+0.2% +$8.02K 1.47% 20
2022
Q2 		$3.8M Buy
40,990
+102
+0.2% +$9.96K 1.31% 22
2022
Q1 		$4.14M Sell
40,888
-490
-1% -$51.5K 1.17% 21
2021
Q4 		$4.27M Buy
41,378
+15
+0% +$1.39K 1.2% 19
2021
Q3 		$3.51M Buy
41,363
+866
+2% +$72.5K 1.04% 26
2021
Q2 		$3.38M Buy
40,497
+567
+1% +$46.4K 0.99% 27
2021
Q1 		$3M Buy
39,930
+1,044
+3% +$76K 0.97% 29
2020
Q4 		$2.66M Sell
38,886
-320
-0.8% -$20.8K 0.9% 31
2020
Q3 		$2.29M Sell
39,206
-3,668
-9% -$228K 0.88% 29
2020
Q2 		$2.79M Buy
42,874
+8,648
+25% +$545K 1.15% 21
2020
Q1 		$2.03M Buy
34,226
+1,140
+3% +$76.1K 1.07% 23
2019
Q4 		$2.46M Buy
33,086
+2,249
+7% +$158K 1.13% 22
2019
Q3 		$1.95M Sell
30,837
-1,889
-6% -$112K 0.99% 30
2019
Q2 		$1.78M Sell
32,726
-7,569
-19% -$408K 0.91% 34
2019
Q1 		$2.17M Buy
40,295
+11,556
+40% +$713K 1.11% 24
2018
Q4 		$1.88M Buy
28,739
+10,853
+61% +$810K 1.11% 23
2018
Q3 		$1.41M Sell
17,886
-90
-0.5% -$6.43K 0.74% 46
2018
Q2 		$1.16M Buy
17,976
+5
+0% +$330 0.68% 45
2018
Q1 		$1.12M Sell
17,971
-616
-3% -$44.2K 0.69% 46
2017
Q4 		$1.35M Sell
18,587
-119
-0.6% -$8.65K 0.84% 44
2017
Q3 		$1.52M Buy
18,706
+3
+0% +$237 1.01% 31
2017
Q2 		$1.5M Buy
18,703
+3,686
+25% +$291K 1% 35
2017
Q1 		$1.18M Buy
15,017
+303
+2% +$24.2K 0.85% 39
2016
Q4 		$1.16M Buy
+14,714
New +$1.19M 0.93% 37

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s CVS Position: Q3 2023 in Review

Sterling Investment Advisors (Pennsylvania) sold out of CVS Health (CVS) in Q3 2023, closing a stake of 39,052 shares — an estimated $2.7M sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in CVS in Q4 2016 and held it in 27 quarters. The position peaked at $4.27M in Q4 2021. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 39,052 CVS Health shares in Q3 2023, an estimated $2.7M.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in CVS Health in Q4 2016 and held it in 27 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s CVS Health position peaked at $4.27M in Q4 2021.
  • 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2023, filed 6 Nov 2023.